[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100476996":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":30,"locations":40,"responsibleParty":68,"collaborators":71,"id":77,"slug":78,"hasResults":79,"nctId":80,"briefTitle":81,"officialTitle":82,"acronym":18,"eligibilityCriteria":83,"healthyVolunteers":84,"sex":85,"minAge":86,"maxAge":18,"enrollmentInfo":87,"targetDuration":18,"studyType":90,"phases":91,"briefSummary":93,"conditions":94,"keywords":96,"overallStatus":42,"whyStopped":18,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":100,"startDateStruct":103,"completionDateStruct":105,"leadSponsor":107,"locationsCount":108},{"fullName":5,"class":6},"Rutgers, The State University of New Jersey","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"TELESCOPE intervention","EXPERIMENTAL","Participants will be surveyed at baseline and at one-week after the scheduled primary care office visit. If a participant is a current smoker then they are offered and navigated to evidence-based smoking cessation. If the participant is interested in screening, an LDCT is ordered. Support for screening, diagnostic testing and oncology care will be provided as needed from the Nurse Navigators.",[13],"Behavioral: TELESCOPE, Remote Decision Coaching with Navigation Intervention",{"label":15,"type":16,"description":17,"interventionNames":18},"Enhanced usual care (EUC)","NO_INTERVENTION","Participants will be surveyed at baseline and at one-week after the scheduled primary care office visit. Primary and secondary outcome data related to the office visit will be collected.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"BEHAVIORAL","TELESCOPE, Remote Decision Coaching with Navigation Intervention","The TELESCOPE intervention involves three complementary components: 1) decision aid and coaching for LCS, 2) referral of current smokers to evidence-based smoking cessation services, and 3) for participants interested in screening, navigation to complete LCS and diagnostic testing and oncology care as needed",[9],[26],{"name":27,"affiliation":28,"role":29},"Anita Y Kinney, PhD, RN","Rutgers Cancer Institute","PRINCIPAL_INVESTIGATOR",[31,36],{"name":32,"role":33,"phone":34,"phoneExt":18,"email":35},"Julie E Chapman-Greene, PhD, MPH","CONTACT","732-865-3375","chapmaje@cinj.rutgers.edu",{"name":37,"role":33,"phone":38,"phoneExt":18,"email":39},"Rebecca Ayala","732-258-6982","raa191@cinj.rutgers.edu",[41,57],{"facility":28,"status":42,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"RECRUITING","New Brunswick","New Jersey","08901","United States","US",{"type":49,"coordinates":50},"Point",[51,52],-74.45182,40.48622,{"lat":52,"lon":51},[55,56],{"name":32,"role":33,"phone":34,"phoneExt":18,"email":35},{"name":37,"role":33,"phone":38,"phoneExt":18,"email":39},{"facility":58,"status":59,"city":60,"state":61,"zip":62,"country":46,"countryCode":47,"cosmosGeoPoint":63,"geoPoint":67,"contacts":18},"The University of Texas MD Anderson Cancer Center","ACTIVE_NOT_RECRUITING","Houston","Texas","77030",{"type":49,"coordinates":64},[65,66],-95.36327,29.76328,{"lat":66,"lon":65},{"type":29,"investigatorFullName":69,"investigatorTitle":70,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Anita Y. Kinney, PhD, RN","Director at Rutgers Cancer Institute",[72,75],{"name":73,"class":74},"National Institutes of Health (NIH)","NIH",{"name":76,"class":74},"National Heart, Lung, and Blood Institute (NHLBI)","100476996","telescope--telehealth-shared-decision-making-coaching-100476996",false,"NCT05491213","TELESCOPE- TELEhealth Shared Decision-making COaching","TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary carE (TELESCOPE)","Inclusion Criteria:\n\n\\- Inclusion Criteria Cluster Randomized Trial\n\nEligibility of patients for the cluster randomized trial will follow United States Preventive Services Task Force criteria for lung cancer screening. Specifically, patients must:\n\n* Be 50 to 77 years of age\n* Be a current or former smoker having quit within the past 15 years\n* Have at least a 20 pack-year smoking history\n* Be scheduled for a non-acute care visit at one of the study sites. Interviews (N=50)\n\nParticipants completing the semi-structured interviews will be:\n\n* A practicing primary care clinician or a clinic director (n=20), nursing director, or clinic practice administrator (n=20) at one of the participating sites or a TELESCOPE study patient navigator (n=7) and nurse navigator (n = 3)\n* Age 18 or older\n* Fluent in English Online surveys (N=130)\n\nProviders completing online PRISM construct surveys will be:\n\n* A practicing primary care provider at one of the participating sites or a TELESCOPE study navigator\n* Age 18 or older\n* Fluent in English\n\nExclusion Criteria:\n\n\\- Cluster Randomized Trial\n\nExcluded will be patients who:\n\n* Do not speak English\n* Have a history lung cancer\n* Were screened for lung cancer within the past 12 months\n* Have health conditions that make them poor candidates for curative treatment as determined by the primary care provider\n* Are unable to provide informed consent Interviews (N=50)\n\nProviders\u002Fadministrators will be excluded if they:\n\n* Are unable to provide informed consent Online surveys (N=130)\n* Are unable to provide informed consent\n* Women who are pregnant. English proficiency is required for the completion of surveys, and the intervention will be conducted in English.",true,"ALL","18 Years",{"count":88,"type":89},594,"ESTIMATED","INTERVENTIONAL",[92],"NA","Hypothesis 1a: The investigators anticipate that navigator decision coaching, compared to enhanced usual care (EUC) will result in higher quality SDM for lung cancer screening (LCS )(primary outcome), greater knowledge of lung cancer screening benefits and harms, and lower decisional conflict.\n\nHypothesis 1b: Compared to enhanced usual care (EUC), we expect that TELESCOPE will result in more screening discussions, increased initial for lung cancer screening (LCS) with low-dose CT scan (LDCT) uptake among interested participants, increased adherence to repeat LCS and diagnostic testing, and increased smoking cessation referrals for current smokers.\n\nHypothesis 2: The investigators expect that a \"booster\" coaching session will increase adherence to repeat lung cancer screening (LCS).",[95],"Lung Neoplasms",[97,98],"Lung cancer screening","Shared decision making","2025-12-02",{"date":101,"type":102},"2025-12-09","ACTUAL",{"date":104,"type":102},"2023-02-14",{"date":106,"type":89},"2027-01-31",{"name":5,"class":6},2]